Taxation Determination

TD 95/33

Income tax: when are 'Factor (f)' payments derived by pharmaceutical companies?

This version is no longer current. Please follow this link to view the current version.

Please note that the PDF version is the authorised version of this ruling.

This document has changed over time. View its history.

FOI status:

may be releasedFOI number: I 1015836

This Determination, to the extent that it is capable of being a 'public ruling' in terms of Part IVAAA of the Taxation Administration Act 1953 , is a public ruling for the purposes of that Part. Taxation Ruling TR 92/1 explains when a Determination is a public ruling and how it is binding on the Commissioner. Unless otherwise stated, this Determination applies to years commencing both before and after its date of issue. However, this Determination does not apply to taxpayers to the extent that it conflicts with the terms of a settlement of a dispute agreed to before the date of issue of the Determination (see paragraphs 21 and 22 of Taxation Ruling TR 92/20).

1. Payments derived by pharmaceutical companies under the Factor (f) program are assessable under either subsection 25(1) or paragraph 26(g) of the Income Tax Assessment Act 1936 . For the reasons set out in Taxation Ruling IT 2669, recipients of Factor (f) payments should account for them by the method that is most appropriate to their business operations. However, subject to section 19, they would generally be regarded as being derived when received by the taxpayer. It is at this time that the recipient has to account for the payments for tax purposes.

2. Prices for pharmaceutical products listed under the Pharmaceutical Benefits Scheme are negotiated by the Pharmaceutical Benefits Pricing Authority and pharmaceutical companies. One of the eight factors to be considered when negotiating prices is the level of Australian activity pricing guideline known as Factor (f) which allows for higher notional prices to be paid to a company in return for approved programs of development and a significant commitment to local production, research and development.

Commissioner of Taxation
29/06/95

Previously issued as Draft TD 93/D228

References

ATO references:
NO AULC 11/711 (Way); NAT 95/4526-3

ISSN: 1038-8982

Related Rulings/Determinations:

TD 93/18
IT 2669

Subject References:
bounty
subsidy

Legislative References:
ITAA 19
ITAA 25(1)
ITAA 26(g)

TD 95/33 history

	Date:	Version:	Change:
You are here	29 June 1995	Original ruling
	12 December 2007	Consolidated ruling	Addendum

Copyright notice

You are free to copy, adapt, modify, transmit and distribute material on this website as you wish (but not in any way that suggests the ATO or the Commonwealth endorses you or any of your services or products).